Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients

Journal of Korean Medical Science

Volumn 19, Issue 2, 2004, Pages 269-274

  Ahn, Sei Hyun ^a   Hwang, Ui Kang ^a   Kwak, Beom Seok ^a   Yoon, Ho Sung ^a   Ku, Bo Kyung ^a   Kang, Hee Jun ^a   Kim, Ji Su ^a   Ko, Byung Kyun ^a   Ko, Chang Dae ^a   Yoon, Kyung Sik ^b   Cho, Dae Yeon ^c   Kim, Jun Suk ^d   Son, Byung Ho ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Eulji University   (South Korea)

^c Doo San Engineering Center   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

BRCA1; Breast Neoplasms; Genes; Koreans; Prevalence

Indexed keywords

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; FEMALE; GEL ELECTROPHORESIS; GENE MUTATION; GERM LINE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OVARY CANCER; PREVALENCE;

EID: 2342621289     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.2.269     Document Type: Article

References (28)

1. Ministry of Health and Welfare, Republic of Korea. Annual report of cancer registry programme in the Republic of Korea (2000.1-2000. 12), 2003.
2. De Leon Matsuda ML, Liede A, Kwan E, Mapua CA, Cutiongco EM, Tan A, Borg A, Narod SA. BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Int J Cancer 2002; 98: 596-603.
3. Robson ME, Boyd J, Borgen PI, Cody HS 3rd. Hereditary breast cancer. Curr Probl Surg 2001; 38: 387-480.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MK. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
5. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rices C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir DR, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
6. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarrson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir RB. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 1996; 56: 3663-5.
7. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjord JE. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 1998; 352: 1337-9.
8. Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. JNatl Cancer Inst 1999; 91: 1241-7.
9. Kang HC, Kim IJ, Park JH, Kwon HJ, Won YJ, Heo SC, Lee SY, Kim KH, Shin Y, Noh DY, Yang DH, Choe KJ, Lee BH, King SB, Park JG. Germline mutations of BRCA1 and BRCA2 in Korean breast and/ or ovarian cancer families. Hum Mutat 2002; 20: 235-9.
10. Neuhausen SL. Ethnic differences in cancer risk resulting from genetic variation. Cancer 1999; 86: 2575-82.
11. Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 2001; 93: 1215-23.
12. Spitzer E, Abbaszadegan MR, Schmidt F, Hauser A, Buwitt U, Lauter FR, Potschick K, Krocker J, Elling D, Grosse R. Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure. Int J Cancer 2000; 85: 474-81.
13. Collins FS. BRCA1-lots of mutations, lots of dilemmas. N Engl J Med 1996; 334: 186-8.
14. Devilee P. BRCA1 and BRCA2 testing: weighing the demand against the benefits. Am J Hum Genet 1999; 64: 943-8.
15. Breast Cancer Information Core (BIC) Database on the World Wide Web AT: http:www.nhgri.nih.gov/intramural research/lab transfer/ bic.
16. Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 2002; 71: 595-606.
17. Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K. Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genet Test 1997; 1: 47-51.
18. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60 percent of ovarian cancer and 30 percent of early-onset breast cancer patients among Ashkenazi women. Am JHum Genet 1997; 60: 505-14.
19. Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 2000; 88: 1393-402.
20. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999; 91: 943-9.
21. Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 2001; 93: 1215-23.
22. Southey MC, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MR, Hopper JL, Venter DJ. BRCA1 mutations and other sequence variations in a population-based sample of Australian women with breast cancer. Br J Cancer 1999; 79: 34-9.
23. Chang J, Hilsenbeck SG, Sng JH, Wong J, Ragu GC. Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients. Clin Cancer Res 2001; 7: 1739-42.
24. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002; 20: 1480-90.
25. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997; 60: 313-9.
26. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL, Jablon L, Cobleigh MA, Hoskins K, Garber JE. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1996; 336: 1409-15.
27. Khoo US, Chan KYK, Cheung ANY, Xue WC, Shen DH, Fung KY, Ngan HYS, Choy KW, Pang CP, Poon CSP, Poon AYA, Ozcelik H. Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mut 2002; 19: 307-8.
28. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am JHum Genet 1998; 62: 676-89.